.png?width=1638&height=869&name=H22025_GLP-1Guide_Graphics_glp-1%20strategy%20(1).png)
omada glp 1 Addressing GLP-1 Costs: Personalized Care Protects ROI What you need to know
Description
Anticipate interim data on first-line efficacy and safety by early 2028
In this review, we will introduce some of the chronic inflammatory diseases and then discuss evidence for beneficial effects of GLP-1-based therapies focusing on its anti-inflammatory actions
Note: The studies listed above show associations, not definitive proof of causation
female individuals were administered a urine dip stick test to exclude pregnancy)
(30, 31) However, they also highlight potential cardiovascular and renal risks, emphasizing the need for careful perioperative monitoring and patient selection
